讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，2月27日南向资金增持2.6万股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持9.85万股。近20个交易日中，获南向资金增持的有11天，累计净增持12.06 万股。截至目前，南向资金持有讯飞医疗科技（02506.HK）523.32万股，占公司已发行普通股的 6.76%。 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 讯飞医疗科技股份有限公司是一家主要从事提供人工智能赋能的医疗解决方案的中国公司。基层医疗服 务业务线由智医助理及慢病管理组成。医院服务业务线包括智慧医院解决方案和诊疗助理。患者服务业 务线包括智慧医院患者服务与诊后管理（包括讯飞晓医App及小程序）、影像云平台以及医疗器械。区 域管理平台解决方案业务线包括智慧卫生解决方案和智慧医保。该公司主要在国内市场开展业务。 证券之星消息，2月26日南向资金减持4000.0股讯飞医疗科技（02506.HK）。近5个交易日中，获南向资 金增持的有3天，累计净增持8.58万股。近20个交易日中，获南向资金增持的有10天，累计净增持5.79万 股。截至目前，南向资金持有讯飞医疗科技（02506.HK）520.72万股，占公司已发行普通股的6.73%。 ...

Group 1 - The core message of the article emphasizes the significant development and opportunities for private enterprises in China, particularly in the context of artificial intelligence (AI) applications [1][7]. - The past year has seen a validation of the belief that it is a prime time for private enterprises and entrepreneurs to showcase their capabilities [2][3]. - AI applications have transitioned from theoretical discussions to practical implementations across various sectors, demonstrating tangible business outcomes [4][5]. Group 2 - In the education sector, AI has been integrated into teaching processes, enhancing personalized learning experiences and improving educational outcomes [5]. - In healthcare, AI tools like the "Smart Medical Assistant" have been deployed in grassroots medical settings, assisting in millions of diagnoses daily without replacing human doctors [6]. - The government has taken steps to support the high-quality development of the private economy, including the implementation of the "Private Economy Promotion Law" [7]. Group 3 - Private enterprises are seen as crucial players in national strategic tasks, leveraging their agility and market responsiveness to drive innovation and technology development [8]. - The establishment of a comprehensive technology ecosystem is underway, focusing on computing power, algorithm migration, and continuous data feedback from industries [8]. - Chinese companies are positioned to respond to global needs with their AI solutions, aiming to expand internationally while fostering local partnerships [9][10]. Group 4 - The company anticipates that its overseas revenue will exceed 1 billion yuan by 2025, highlighting its growth in international markets [10]. - Chinese advancements in AI technologies, such as multi-modal understanding and multi-language translation, place the country at the forefront of global innovation [10]. - The ultimate goal of AI is to enhance human capabilities, allowing individuals to leverage AI to become more valuable and unique [10].

Core Viewpoint - The company iFlytek aims to position itself as a global leader in AI language models, providing a second choice for the world amidst intense global AI competition, with a strategic focus on the ASEAN market through its operations in Guangxi [1][8]. Group 1: Strategic Positioning - iFlytek's chairman emphasized the company's strategic goal of offering a second choice globally, highlighting its ambition to compete with international leaders in AI [1]. - The company has established a fully-owned subsidiary in Nanning, Guangxi, positioning the region as a core hub for its international strategy, focusing on technology adaptation and model validation before expanding into ASEAN [3][6]. Group 2: Regional Development and Partnerships - Guangxi's transformation from a peripheral economic region to a central hub for AI export is attributed to its unique geographical position and recent trade agreements, such as RCEP [2]. - Major tech companies like Huawei and Tencent are investing heavily in Guangxi, indicating a growing ecosystem for AI development and deployment [2]. Group 3: Language as a Lever - Language barriers are identified as the primary challenge for business in ASEAN, with iFlytek focusing on breaking these barriers as a core product offering [4][5]. - A strategic partnership with Guangxi's government aims to enhance research on non-standard languages in ASEAN, supporting various sectors like trade and education [4][6]. Group 4: AI Implementation and Expansion - iFlytek is developing a comprehensive AI implementation model in Guangxi, targeting sectors such as education and healthcare, which face significant challenges and have high demand [6][7]. - The company plans to replicate its successful "Guangxi experience" as an "ASEAN solution," with a focus on a multi-language AI model that supports the primary languages of ASEAN countries [7]. Group 5: Global Outreach and Future Vision - iFlytek's international expansion has accelerated, with partnerships established in various regions, including Southeast Asia, the Middle East, and North America, covering over 50 countries [8]. - The company envisions a new paradigm for Chinese technology exports in the AI era, focusing on systematic capability transfer and ecosystem integration rather than mere product sales [8].

Core Viewpoint - The article emphasizes iFlytek's strategic positioning as a provider of multilingual large models, aiming to offer a second choice to the world in the context of global AI competition [1][3]. Group 1: Strategic Positioning - iFlytek's strategy includes leveraging Guangxi as a core hub for internationalization, utilizing its unique geographical position and language resources to adapt AI technologies for ASEAN markets [3][4]. - The establishment of a wholly-owned subsidiary and an AI innovation research institute in Nanning, Guangxi, marks a significant step in iFlytek's international strategy [4][9]. Group 2: Language Barrier Solutions - Language is identified as the primary barrier to business in ASEAN, with iFlytek focusing on breaking this barrier through its translation solutions [6][8]. - A strategic cooperation agreement with Guangxi aims to develop research on non-common languages in ASEAN, enhancing communication for trade and education [6][9]. Group 3: Experience Accumulation and Output - iFlytek is accumulating "Guangxi experience" by deeply engaging in education, healthcare, and governance sectors, which are characterized by high barriers and significant pain points [9][10]. - The company plans to replicate its successful "Guangxi experience" as an "ASEAN solution," with a focus on a comprehensive AI implementation loop [10][11]. Group 4: Ecosystem Development - iFlytek is actively signing partnerships to build a regional intelligent ecosystem, collaborating with various organizations to enhance digital infrastructure and cultural exchange [13][14]. - The launch of the "Spark ASEAN Multilingual Large Model Base" aims to support ten major languages in ASEAN, showcasing iFlytek's commitment to localized AI solutions [11][16]. Group 5: Global Expansion - iFlytek's overseas expansion has accelerated, with strategic partnerships established in education, healthcare, and telecommunications across Southeast Asia, the Middle East, and North America [14][16]. - The company aims to create a unique advantage through a combination of self-control, industry application, and multilingual capabilities, positioning itself as a leader in the AI export market [16].

Core Insights - The conference held by iFlytek on February 13, 2026, focused on the theme "Courageous Progress, Vast Sky" and reviewed the company's achievements in 2025 while outlining strategic directions for 2026 [1] Financial Performance - In 2025, iFlytek achieved over 27 billion yuan in operating revenue, with operating cash flow reaching a record high of 3 billion yuan, representing a year-on-year growth of 28% [1] - The company's profit scale increased by 40% year-on-year, reaching 7 billion yuan [1] Industry Applications and International Market - iFlytek's medical large model achieved industry-leading key performance indicators, with its intelligent medical assistant completing over 1.1 billion diagnoses [1] - The company's overseas revenue surpassed 1 billion yuan [1] Strategic Focus for 2026 - For 2026, iFlytek has identified four key initiatives: maintaining strategic focus, enhancing systematic innovation, deepening project-based approaches, and accelerating talent development [1] - A transformation management committee has been established to drive AI-driven organizational efficiency upgrades [1] AI and Workforce - The chairman emphasized that AI will not replace humans but will eliminate those who do not adapt their work methods [1] - iFlytek aims to invest in tools, training capabilities, and talent development mechanisms to provide growth opportunities for every employee [1]

Core Viewpoint - The article discusses the recent trading activity of iFlytek Medical Technology (02506.HK), highlighting the fluctuations in southbound capital holdings and the company's focus on AI-enabled healthcare solutions [1] Group 1: Southbound Capital Activity - On February 13, southbound capital increased its holdings in iFlytek Medical Technology by 19,500 shares [1] - Over the past five trading days, there were three days of net reductions, totaling 283,600 shares [1] - In the last 20 trading days, there were ten days of net increases, amounting to 40,700 shares [1] - Currently, southbound capital holds 5,154,200 shares of iFlytek Medical Technology, representing 6.66% of the company's issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled healthcare solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-discharge management) [1] - The company also offers regional management platform solutions, including smart health solutions and smart medical insurance [1] - iFlytek Medical Technology mainly operates in the domestic market [1]

Core Viewpoint - Southbound funds increased their holdings in iFlytek Medical Technology (02506.HK) by 13,400 shares on February 12, indicating a fluctuating interest from investors in the company [1] Group 1: Southbound Fund Activity - Over the past five trading days, there were three days of net reductions in holdings, totaling a decrease of 227,900 shares [1] - In the last twenty trading days, there were ten days of net increases, with a total increase of 326,000 shares [1] - As of now, southbound funds hold 5,134,800 shares of iFlytek Medical Technology, representing 6.63% of the company's total issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (comprising intelligent medical assistants and chronic disease management), hospital services (including smart hospital solutions and diagnostic assistants), and patient services (such as smart hospital patient services and post-discharge management) [1] - The regional management platform solutions business line includes smart health solutions and smart medical insurance [1]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in iFlytek Medical Technology (02506.HK) by 186,500 shares on February 10, 2026, marking a decrease of 3.44% [1][2] - Over the past five trading days, there have been four days of reductions in holdings, totaling a net decrease of 210,700 shares [1] - In the last 20 trading days, there were 11 days of increased holdings, with a cumulative net increase of 1,308,000 shares [1] Group 2 - As of now, southbound funds hold 5,231,600 shares of iFlytek Medical Technology, which represents 6.76% of the company's total issued ordinary shares [1] - The company primarily engages in providing AI-powered medical solutions, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2] - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [2]

Core Viewpoint - The southbound capital has increased its holdings in iFlytek Medical Technology (02506.HK), indicating growing investor interest in the company, particularly in the context of its AI-enabled healthcare solutions [1][2]. Group 1: Shareholding Changes - On February 6, 2026, southbound capital increased its holdings by 75,200 shares, representing a 1.40% increase [2]. - Over the past five trading days, there were two days of net increases, totaling 140,300 shares [1]. - In the last 20 trading days, there were 12 days of net increases, amounting to 1,661,200 shares [1]. Group 2: Current Shareholding Status - As of February 6, 2026, southbound capital holds 5,437,800 shares of iFlytek Medical Technology, which accounts for 7.02% of the company's total issued ordinary shares [1][2]. Group 3: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-enabled healthcare solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2].